학술논문

A Phase I/II Investigation of Safety and Efficacy of Nivolumab and nab-Sirolimus in Patients with a Variety of Tumors with Genetic Mutations in the mTOR Pathway
Document Type
Article
Source
In: Anticancer Research. (Anticancer Research, May 2023, 43(5):1993-2002)
Subject
Language
English
ISSN
17917530
02507005